Table 2.
Circulating EV-associated ANXA2 levels according to the clinical characteristics of EC patients.
| Fiture | n | ANXA2 (ng/uL) Mean (SD) | p |
|---|---|---|---|
| Age | |||
| <68 | 19 | 0.163 (0.059) | |
| ≥68 | 22 | 0.179 (0.066) | 0.23 |
| FIGO | |||
| I/II | 32 | 0.157 (0.059) | |
| III/IV | 9 | 0.199 (0.058) | 0.043 |
| Histologic type | |||
| Endometrioid | 26 | 0.150 (0.061) | |
| Non-endmetrioid | 12 | 0.189 (0.051) | 0.019 |
| Histologic grade | |||
| Grade 1–2 | 26 | 0.168 (0.063) | |
| Grade 3 | 14 | 0.191 (0.054) | 0.038 |
| Myometrial infiltration | |||
| <50 | 17 | 0.158 (0.066) | |
| ≥50 | 23 | 0.175 (0.059) | 0.385 |
| Risk of recurrence | |||
| Low/intermediate | 17 | 0.147 (0.070) | |
| high | 24 | 0.188 (0.049) | 0.012 |
SD, standard deviation; p was calculated according to Mann–Whitney U test. p < 0.05 are marked in bold.